Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
In November, the FDA gave its manufacturer, Eli Lilly, the green light to market the medication for the treatment of obesity
First, it signals the pancreas to release insulin to pick up the glucose thats coming in
Zepbound has FDA-reviewed labeling and manufacturing
Tirzepatide (Mounjaro/Zepbound) already delivers 15-22% body weight loss through dual GIP/GLP-1 receptor activation - making it one of the most powerful single-agent options available
The only difference is the FDA-approved indication: Zepbound is approved for chronic weight management and sleep apnea, while Mounjaro is approved for type 2 diabetes
US$ 20.81
US$ 27.22
US$ 29.85
US$ 29.72
US$ 25.11
US$ 23.74
US$ 22.33
US$ 27.22
US$ 27.52
US$ 21.36
US$ 23.29
